NCT06512129 Defining Volume Status in Sepsis With Extracellular Water Measurement
| NCT ID | NCT06512129 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Uppsala University |
| Condition | Sepsis |
| Study Type | OBSERVATIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-03-01 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20 participants in total. It began in 2025-03-01 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to learn about the influence of extracellular water on volume status in adult sepsis patients presenting with hemodynamic instability. The main question it aims to answer is: • Can measurement of extracellular water (MoistureMeterD, Delfin Technologies Ltd, Kuopio, Finland) contribute to the description of hemodynamic instability in adult sepsis patients. Patients with sepsis admitted to intensive care will receive standard care with the addition of measurement of extracellular water.
Eligibility Criteria
Inclusion Criteria: * Adults with sepsis. Exclusion Criteria: * Pregnancy, other than sepsis known cause of shock.
Contact & Investigator
Annelie Barrueta Tenhunen, MD, PhD
PRINCIPAL INVESTIGATOR
Uppsala University, Region Uppsala
Frequently Asked Questions
Who can join the NCT06512129 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Sepsis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06512129 currently recruiting?
Yes, NCT06512129 is actively recruiting participants. Contact the research team at annelie.barrueta@uu.se for enrollment information.
Where is the NCT06512129 trial being conducted?
This trial is being conducted at Uppsala, Sweden.
Who is sponsoring the NCT06512129 clinical trial?
NCT06512129 is sponsored by Uppsala University. The principal investigator is Annelie Barrueta Tenhunen, MD, PhD at Uppsala University, Region Uppsala. The trial plans to enroll 20 participants.